Evidence map›Paper›PMID 34677478›Full record

ArticleMarine drugs2021

Marzia Vasarri, Manuela Leri, Emanuela Barletta, Carlo Pretti, Donatella Degl'Innocenti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Ameliorative Effect ofInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marzia VasarriDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.ORCID 0000-0002-4241-3992
Manuela LeriDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.ORCID 0000-0002-3785-0805
Emanuela BarlettaDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.ORCID 0000-0001-7493-1498
Carlo PrettiInteruniversity Center of Marine Biology and Applied Ecology "G. Bacci" (CIBM), Viale N. Sauro 4, 57128 Livorno, Italy.
Donatella Degl'InnocentiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.ORCID 0000-0002-3342-5537

Funding

University of Florence Fondi di Ateneo 2021 to D.D.I.
6 · The paper itself

Abstract

Neuroblastoma (NB) is a common cancer in childhood, and lethal in its high-risk form, primarily because of its high metastatic potential. Targeting cancer cell migration, and thus preventing metastasis formation, is the rationale for more effective cancer therapy against NB. Previous studies have described the leaf extract from

Indexed as

AlismatalesAnimalsAntineoplastic AgentsAquatic OrganismsCell Line, TumorCell MovementHumansNeuroblastomaPhytotherapyPlant ExtractsAntineoplastic AgentsPlant Extractsautophagycell migrationgelatinasenatural compoundsneuroblastomaPosidonia oceanica

Identifiers

PMID34677478
PMCPMC8539885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.